Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC Rebamipide 90098-04-7 1g
Supplier: Apexbio Technology LLC B20181000
Rebamipide (CAS 90098-04-7) is a small molecule administered orally and recognized for its gastroprotective properties Its primary mechanism involves upregulation of cyclooxygenase-2 (COX-2) expression which leads to increased endogenous prostaglandin synthesis particularly prostaglandin E2 (PGE2) thereby enhancing gastric mucosal defense Studies also indicate that rebamipide can inhibit the proliferation of gastric cancer cells This compound is utilized in research investigating the mechanisms underlying gastric mucosal injury peptic ulcer disease gastritis and gastric cancer
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?